143 related articles for article (PubMed ID: 33780252)
21. Overexpression of semaphorin 3A in patients with urothelial cancer.
Vadasz Z; Rubinstein J; Bejar J; Sheffer H; Halachmi S
Urol Oncol; 2018 Apr; 36(4):161.e1-161.e6. PubMed ID: 29288007
[TBL] [Abstract][Full Text] [Related]
22. Reduced expression of GATA3 predicts progression in non-muscle invasive urothelial carcinoma of the urinary bladder.
Kamel NA; Abdelzaher E; Elgebaly O; Ibrahim SA
J Histotechnol; 2020 Mar; 43(1):21-28. PubMed ID: 31551051
[TBL] [Abstract][Full Text] [Related]
23. The use of urinary nuclear matrix protein 22 (NMP22) as a diagnostic adjunct to urine cytology for monitoring of recurrent bladder cancer--institutional experience and review.
Önal B; Han Ü; Yilmaz S; Köybasioglu F; Altuğ U
Diagn Cytopathol; 2015 Apr; 43(4):307-14. PubMed ID: 25488052
[TBL] [Abstract][Full Text] [Related]
24. Significance of Serum N-glycan Profiling as a Diagnostic Biomarker in Urothelial Carcinoma.
Oikawa M; Hatakeyama S; Yoneyma T; Tobisawa Y; Narita T; Yamamoto H; Hashimoto Y; Koie T; Narita S; Sasaki A; Tsuchiya N; Habuchi T; Takahashi I; Nakaji S; Ohyama C
Eur Urol Focus; 2018 Apr; 4(3):405-411. PubMed ID: 28753809
[TBL] [Abstract][Full Text] [Related]
25. Quantitative Proteomic Analysis Identifies AHNAK (Neuroblast Differentiation-associated Protein AHNAK) as a Novel Candidate Biomarker for Bladder Urothelial Carcinoma Diagnosis by Liquid-based Cytology.
Lee H; Kim K; Woo J; Park J; Kim H; Lee KE; Kim H; Kim Y; Moon KC; Kim JY; Park IA; Shim BB; Moon JH; Han D; Ryu HS
Mol Cell Proteomics; 2018 Sep; 17(9):1788-1802. PubMed ID: 29950347
[TBL] [Abstract][Full Text] [Related]
26. Changes in Urinary Exosomal Nuclear Matrix Protein-22 in Dogs With Urothelial Carcinoma: A Pilot Study.
Shin JH; An JH; Park SM; Lim GH; Seo KW; Youn HY
In Vivo; 2024; 38(1):190-195. PubMed ID: 38148062
[TBL] [Abstract][Full Text] [Related]
27. Human Epidermal Growth Factor Receptor 2 Overexpression in Micropapillary and Other Variants of Urothelial Carcinoma.
Behzatoğlu K; Yörükoğlu K; Demir H; Bal N
Eur Urol Focus; 2018 Apr; 4(3):399-404. PubMed ID: 28753766
[TBL] [Abstract][Full Text] [Related]
28. Large-Scale SRM Screen of Urothelial Bladder Cancer Candidate Biomarkers in Urine.
Duriez E; Masselon CD; Mesmin C; Court M; Demeure K; Allory Y; Malats N; Matondo M; Radvanyi F; Garin J; Domon B
J Proteome Res; 2017 Apr; 16(4):1617-1631. PubMed ID: 28287737
[TBL] [Abstract][Full Text] [Related]
29. Discovery of novel bladder cancer biomarkers by comparative urine proteomics using iTRAQ technology.
Chen YT; Chen CL; Chen HW; Chung T; Wu CC; Chen CD; Hsu CW; Chen MC; Tsui KH; Chang PL; Chang YS; Yu JS
J Proteome Res; 2010 Nov; 9(11):5803-15. PubMed ID: 20806971
[TBL] [Abstract][Full Text] [Related]
30.
Sakai K; Maeda S; Saeki K; Yoshitake R; Goto-Koshino Y; Nakagawa T; Nishimura R; Yonezawa T; Matsuki N
Vet Pathol; 2020 Jan; 57(1):56-65. PubMed ID: 31640537
[TBL] [Abstract][Full Text] [Related]
31. Panel of Urinary Diagnostic Markers for Non-Invasive Detection of Primary and Recurrent Urothelial Urinary Bladder Carcinoma.
Soukup V; Kalousová M; Capoun O; Sobotka R; Breyl Z; Pešl M; Zima T; Hanuš T
Urol Int; 2015; 95(1):56-64. PubMed ID: 25662337
[TBL] [Abstract][Full Text] [Related]
32. Acrolein contributes to urothelial carcinomas in patients with chronic kidney disease.
Hong JH; Lee PAH; Lu YC; Huang CY; Chen CH; Chiang CH; Chow PM; Jaw FS; Wang CC; Huang CY; Wang TW; Liu JH; Wang HT
Urol Oncol; 2020 May; 38(5):465-475. PubMed ID: 32199754
[TBL] [Abstract][Full Text] [Related]
33. Wnt5a / planar cell polarity signaling pathway in urothelial carcinoma, a potential prognostic biomarker.
Saling M; Duckett JK; Ackers I; Coschigano K; Jenkinson S; Malgor R
Oncotarget; 2017 May; 8(19):31655-31665. PubMed ID: 28427201
[TBL] [Abstract][Full Text] [Related]
34. Oncologic Outcomes of Post-Kidney Transplantation Superficial Urothelial Carcinoma.
Huang GL; Luo HL; Chen YT; Cheng YT
Transplant Proc; 2018 May; 50(4):998-1000. PubMed ID: 29731099
[TBL] [Abstract][Full Text] [Related]
35. Detection of Copy Number Imbalance in Canine Urothelial Carcinoma With Droplet Digital Polymerase Chain Reaction.
Mochizuki H; Shapiro SG; Breen M
Vet Pathol; 2016 Jul; 53(4):764-72. PubMed ID: 26574558
[TBL] [Abstract][Full Text] [Related]
36. Plasma thymosin-α1 level as a potential biomarker in urothelial and renal cell carcinoma.
Jou YC; Tsai YS; Hsieh HY; Chen SY; Tsai HT; Chen KJ; Wang ST; Shiau AL; Wu CL; Tzai TS
Urol Oncol; 2013 Nov; 31(8):1806-11. PubMed ID: 22609059
[TBL] [Abstract][Full Text] [Related]
37. Emerging biomarkers for the diagnosis and monitoring of urothelial carcinoma.
Miyake M; Owari T; Hori S; Nakai Y; Fujimoto K
Res Rep Urol; 2018; 10():251-261. PubMed ID: 30588457
[TBL] [Abstract][Full Text] [Related]
38. Detection of pagetoid urothelial intraepithelial neoplasia extending to the vagina by cervical screening cytology: a case report with renewed immunochemical summary.
Koyanagi Y; Kubo C; Nagata S; Ryu A; Hatano K; Kano R; Tanada S; Ashimura JI; Idota A; Kamiura S; Yamasaki T; Nakatsuka SI
Diagn Pathol; 2019 Feb; 14(1):9. PubMed ID: 30711015
[TBL] [Abstract][Full Text] [Related]
39. Bikunin loss in urine as useful marker for bladder carcinoma.
Tsui KH; Tang P; Lin CY; Chang PL; Chang CH; Yung BY
J Urol; 2010 Jan; 183(1):339-44. PubMed ID: 19914646
[TBL] [Abstract][Full Text] [Related]
40. Alteration in serum concentrations of FGF19, FGF21, and FGF23 in patients with urothelial carcinoma.
Li JR; Chiu KY; Ou YC; Wang SS; Chen CS; Yang CK; Ho HC; Cheng CL; Yang CR; Chen CC; Wang SC; Lin CY; Hung SC; Hsu CY; Chen CJ
Biofactors; 2019 Jan; 45(1):62-68. PubMed ID: 30334297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
